LitAlert ~~ GeneLit.com

    • Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore.
    • Ng PS, Boonen RACM, Wijaya E, Chong CE, Sharma M, Knaup S, Mariapun S, Ho WK, Lim J, Yoon SY, Taib NAM, See MH, Li J, Lim SH, Tan EY, Tan VK, Tan SM, Tan VK, van Dam RM, Rahmat K, Yip CH, Carvalhom S, Luccarini , Baynes C, Dunning AM, Antoniou A, van Attikum H, Easton DF, Hartman M, Teo SH.
    • J Med Genet. 2021 Apr 2:jmedgenet-2020-107471. doi: 10.1136/jmedgenet-2020-107471. Epub ahead of print.
    • Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer.
    • Henderson V, Chukwudozie IB, Comer-Hagans D, Coffey V, Grumbach G, Spencer S, Rodgers C, Kaur R, Newsome J, Balay L, Maga T, Kendall L, Balthazar C, Watson K, Winn R, Odoms-Young A, Hoskins KF.
    • Cancer. 2021 Apr 1. doi: 10.1002/cncr.33525. Epub ahead of print.
    • Synthetic Lethality in Cancer Therapeutics: The Next Generation.
    • Setton J, Zinda M, Riaz N, Durocher D, Zimmermann M, Koehler M, Reis-Filho JS, Powell SN.
    • Cancer Discov. 2021 Apr 1. doi: 10.1158/2159-8290.CD-20-1503. Epub ahead of print.
    • Review
    • Should the BCRA1/2-mutations healthy carriers be valid candidates for hematopoietic stem cell donation?
    • Fresa A, Sica S.
    • Hered Cancer Clin Pract. 2021 Apr 1;19(1):22. doi: 10.1186/s13053-021-00179-w.
    • Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
    • Ledet EM, Burgess EF, Sokolova AO, Jaeger EB, Hatton W, Moses M, Miller P, Cotogno P, Layton J, Barata P, Lewis BE, Nakazawa M, Zhu J, Dellinger B, Elrefai S, Nafissi NN, Egan JB, Shore N, McKay RR, Bryce AH, Cheng HH, Antonarakis ES, Sartor O.
    • Prostate. 2021 Apr 1. doi: 10.1002/pros.24123. Epub ahead of print.
    • Systemic alterations play a dominant role in epigenetic predisposition to breast cancer in offspring of obese fathers and is transmitted to a second generation.
    • Fontelles CC, da Cruz RS, Gonsiewski AK, Barin E, Tekmen V, Jin L, Cruz MI, Loudig O, Warri A, de Assis S.
    • Sci Rep. 2021 Apr 1;11(1):7317. doi: 10.1038/s41598-021-86548-w.
    • Risikoadaptierte Früherkennung des Prostatakarzinoms – Update 2021 [Risk-adapted prostate cancer screening-update 2021].
    • Al-Monajjed R, Arsov C, Albers P.
    • Urologe A. 2021 Apr 1. German. doi: 10.1007/s00120-021-01505-9. Epub ahead of print.
    • Review, [Article in German]
    • Determinants of serum adiponectin levels: a cross-sectional study.
    • Sattarinezhad A, Rasekhi Kazerouni A, Omrani GR, Shams M.
    • Horm Mol Biol Clin Investig. 2021 Mar 31. doi: 10.1515/hmbci-2020-0057. Epub ahead of print.
    • Decision-making for Risk-reducing Salpingo-oophorectomy (RRSO) in Southeast Asian BRCA Mutation Carriers With Breast Cancer: A Qualitative Study.
    • Sa'at H, Lee YK, Yoon SY, Wong SW, Woo YL, Barlow-Stewart K, Mohd Taib NA.
    • Int J Behav Med. 2021 Mar 31. doi: 10.1007/s12529-021-09984-y. Epub ahead of print.
    • Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study.
    • Bartley N, Best M, Butow P.
    • J Genet Couns. 2021 Mar 31. doi: 10.1002/jgc4.1398. Epub ahead of print.
    • Understanding Breast Implant Risks.
    • Spittal K.
    • FORCE. XRAY. 2021 Mar 30.
    • Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
    • Sabol RA, Ledet EM, Jaeger E, Hatton W, Moses M, Lankford A, Zaheria A, Barata P, Layton JL, Lewis BE, Sartor O.
    • Prostate. 2021 Mar 24. doi: 10.1002/pros.24120. Epub ahead of print.
    • [The Treatment of Olaparib for BRCA Positive-Metastatic Breast Cancer Patient].
    • Yamamoto D, Yamamoto C, Okugawa H, Tsubota Y, Kawakami K.
    • Gan To Kagaku Ryoho. 2021 Mar;48(3):455-456. Japanese.
    • Case report, [Article in Japanese]